🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G8128Y157 (prev. 00B9GTXM6 )
- Market Cap
- Small Cap
- IPO
- 9/8/2020 · $5.80/share
- ADR Ratio
- 1:3
Business: Silence Therapeutics Plc develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.
Company Contact
- CEO
- Mark Rothera
- CFO
- Craig Tooman
- Investor Relations
- Peter Vozzo, Westwicke Partners · 443-213-0505 · peter.vozzo@westwicke.com